SCHEMBL8802648

SCHEMBL8802648

CC1=C(C)c2cc3ccccc3cc2C1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 1/20 0.50
▸ MAOB P27338 1/20 0.50
▸ CDC25A P30304 3/20 0.43
▸ CDC25B P30305 3/20 0.43
▸ GSTP1 P09211 1/20 0.43
▸ ELANE P08246 1/20 0.43
▸ AURKA O14965 1/20 0.43
▸ AURKB Q96GD4 1/20 0.43
▸ ILF3 Q12906 1/20 0.41
▸ GAPDH P04406 1/20 0.41
▸ S100A4 P26447 2/20 0.41
▸ PTGS2 P35354 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ CYP2A6 P11509 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ MAP2K7 O14733 2/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11051134 0.95 MAOA (0.54) MAOAMAOBCDC25ACDC25BGSTP1
SCHEMBL4279434 0.93 MAOA (0.43) MAOAMAOBCDC25ACDC25BGSTP1
SCHEMBL27935063 0.91 MAOA (0.50) MAOAMAOBCDC25ACDC25BGSTP1
SCHEMBL27916612 0.91 MAOA (0.50) MAOAMAOBCDC25ACDC25BGSTP1
SCHEMBL11864498 0.81 IDO1 (0.46) MAOAMAOBCDC25ACDC25BGSTP1
SCHEMBL30130196 0.80 MEN1 (0.56) MAOACDC25BGSTP1ELANEILF3
SCHEMBL29364188 0.80 MEN1 (0.56) MAOACDC25BGSTP1ELANEILF3
SCHEMBL354514 0.80 MEN1 (0.56) MAOACDC25BGSTP1ELANEILF3
SCHEMBL9429592 0.79 ELANE (0.50) CDC25BGSTP1ELANEILF3GAPDH
SCHEMBL16144676 0.78 MEN1 (0.53) MAOACDC25BGSTP1ELANEILF3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0800504-A1 TRICYCLIC RETINOIDS, METHODS FOR THEIR PRODUCTION AND USE LIGAND PHARMACEUTICALS, INC. (US) 1997-10-15 — — EP disclosed
Send feedback